Although its role is clearly smaller than that of TTN, whose mutations have recently been shown to occur in up to 25% of DCM patients [25] our results indicate that, at least in Polish population, a systematic screening of BAG3 should be offered to DCM patients. Here, BAG3 is linked to familial dilated cardiomyopathy.